Within the past month, we have received news of a distributor agreement, a crackerjack of an investor update, and now this, hiring this consultant, Christine Huynh (the Director, no less), for us to make a move into finfish aquaculture commercialization. Not only are we going to be dominant in shrimp production in the USA but will make a splash (pun intended) w/ the 2nd most favorite seafood, salmon. From the recent update:
enjoy the ride, WBeacham
She is the Director at Nautilus Collaboration ... In this role, Christine is consulting to NAS to further the commercial research for applications in the aquaculture industry, and leads the research being conducted at the Marineholmen RASLab in Bergen, Norway. RASLab will be working closely with NAS in further exploring potential welfare benefits of the application of hydrogas and the incorporation of electrocoagulation. Christine is an excellent liaison between NAS and RASLab where the commercialization and further development of NAS technologies have wider applications in the finfish aquaculture sector. There are potential applications for electrocoagulation and reducing gas (hydrogas) in aquaculture production and wastewater processing, that will improve the sustainability of the industry and fish welfare. The Company believes that these trial results will directly lead to significant licensing opportunities.Quote:At this stage of commercialization, with weekly production on track for the first quarter of 2022, we have numerous sales channel partners in place. We are now highly focused on attracting customers and finalizing customer agreements with distributors and processors for long term supply agreements.
enjoy the ride, WBeacham
1
